BALCHEM CORPORATION (BCPC, Financial) filed Quarterly Report for the period ended 2009-03-31.
Balchem Corporation is engaged in the development manufacture and marketing of specialty performance ingredients for the food feed and medical sterilization industries. They operate in two business segments the micro-encapsulation of performance ingredients and the repackaging and marketing of high quality specialty gases. They sell their products through their own sales force independent distributors and sales agents. BALCHEM CORPORATION has a market cap of $446.4 million; its shares were traded at around $24.4 with a P/E ratio of 24.2 and P/S ratio of 2. The dividend yield of BALCHEM CORPORATION stocks is 0.4%. BALCHEM CORPORATION had an annual average earning growth of 25.9% over the past 5 years.
Weighted
Weighted Aggregate Average
Average Intrinsic Remaining
For the three months Exercise Value Contractual
ended March 31, 2009 Shares (000s) Price ($000s) Term
-
Outstanding as of
December 31, 2008 2,396 $ 13.82 $ 26,873
Granted - -
Exercised (79) 8.90
Expired - -
Forfeited (3) 19.54
-
Outstanding as of
March 31, 2009 2,314 $ 13.97 $ 26,037 6.5
-
Exercisable as of
March 31, 2009 1,675 $ 10.79 $ 24,020 5.5
-
-
Weighted
Weighted Aggregate Average
Average Intrinsic Remaining
For the three months Exercise Value Contractual
ended March 31, 2008 Shares (000s) Price ($000s) Term
-
Outstanding as of
December 31, 2007 1,944 $ 10.66 $ 22,786
Granted 307 20.41
Exercised (47) 8.78
Expired - -
Forfeited - -
-
Outstanding as of
March 31, 2008 2,204 $ 12.05 $ 23,947 6.9
-
Exercisable as of
March 31, 2008 1,456 $ 9.12 $ 20,088 6.0
-
-
Three Months Ended
March 31,
2009 2008
-
Weighted-average fair value of options granted $ N/A $ 6.38
Total intrinsic value of stock options exercised ($000s) $ 1,027 $ 610
-
-
Weighted
Average Grant
Date Fair
Three months ended March 31, 2009 Shares (000s) Value
-
Non-vested balance as of December 31, 2008 232 $ 20.08
Granted - -
Vested - -
Forfeited - -
-
Non-vested balance as of March 31, 2009 232 $ 20.08
-
-
Weighted
Average Grant
Date Fair
Three months ended March 31, 2008 Shares (000s) Value
-
Non-vested balance as of December 31, 2007 118 $ 16.49
Granted 73 20.77
Vested - -
Forfeited - -
-
Non-vested balance as of March 31, 2008 191 $ 18.10
-
-
Gross Gross
Amortization Carrying Accumulated Carrying Accumulated
Period Amount at Amortization Amount at Amortization
(in years) 3/31/09 at 3/31/09 12/31/08 at 12/31/08
-
Customer lists 10 $34,150 $ 7,449 $34,150 $ 6,595
Regulatory re-registration
costs 10 85 5 85 3
Patents & trade secrets 15-17 1,682 431 1,673 406
Trademarks & trade names 17 908 211 904 198
Other 5-10 563 254 619 236
-
$37,388 $ 8,350 $37,431 $7,438
-
-
Three Months Ended
March 31,
2009 2008
-
Specialty Products $ 8,794 $ 8,450
Food, Pharma & Nutrition 8,304 9,289
Animal Nutrition & Health 35,888 39,122
-
Total $ 52,986 $ 56,861
-
Read the The complete Report
Balchem Corporation is engaged in the development manufacture and marketing of specialty performance ingredients for the food feed and medical sterilization industries. They operate in two business segments the micro-encapsulation of performance ingredients and the repackaging and marketing of high quality specialty gases. They sell their products through their own sales force independent distributors and sales agents. BALCHEM CORPORATION has a market cap of $446.4 million; its shares were traded at around $24.4 with a P/E ratio of 24.2 and P/S ratio of 2. The dividend yield of BALCHEM CORPORATION stocks is 0.4%. BALCHEM CORPORATION had an annual average earning growth of 25.9% over the past 5 years.
Highlight of Business Operations:
-Weighted
Weighted Aggregate Average
Average Intrinsic Remaining
For the three months Exercise Value Contractual
ended March 31, 2009 Shares (000s) Price ($000s) Term
-
Outstanding as of
December 31, 2008 2,396 $ 13.82 $ 26,873
Granted - -
Exercised (79) 8.90
Expired - -
Forfeited (3) 19.54
-
Outstanding as of
March 31, 2009 2,314 $ 13.97 $ 26,037 6.5
-
Exercisable as of
March 31, 2009 1,675 $ 10.79 $ 24,020 5.5
-
-
Weighted
Weighted Aggregate Average
Average Intrinsic Remaining
For the three months Exercise Value Contractual
ended March 31, 2008 Shares (000s) Price ($000s) Term
-
Outstanding as of
December 31, 2007 1,944 $ 10.66 $ 22,786
Granted 307 20.41
Exercised (47) 8.78
Expired - -
Forfeited - -
-
Outstanding as of
March 31, 2008 2,204 $ 12.05 $ 23,947 6.9
-
Exercisable as of
March 31, 2008 1,456 $ 9.12 $ 20,088 6.0
-
-
Three Months Ended
March 31,
2009 2008
-
Weighted-average fair value of options granted $ N/A $ 6.38
Total intrinsic value of stock options exercised ($000s) $ 1,027 $ 610
-
-
Weighted
Average Grant
Date Fair
Three months ended March 31, 2009 Shares (000s) Value
-
Non-vested balance as of December 31, 2008 232 $ 20.08
Granted - -
Vested - -
Forfeited - -
-
Non-vested balance as of March 31, 2009 232 $ 20.08
-
-
Weighted
Average Grant
Date Fair
Three months ended March 31, 2008 Shares (000s) Value
-
Non-vested balance as of December 31, 2007 118 $ 16.49
Granted 73 20.77
Vested - -
Forfeited - -
-
Non-vested balance as of March 31, 2008 191 $ 18.10
-
-
Gross Gross
Amortization Carrying Accumulated Carrying Accumulated
Period Amount at Amortization Amount at Amortization
(in years) 3/31/09 at 3/31/09 12/31/08 at 12/31/08
-
Customer lists 10 $34,150 $ 7,449 $34,150 $ 6,595
Regulatory re-registration
costs 10 85 5 85 3
Patents & trade secrets 15-17 1,682 431 1,673 406
Trademarks & trade names 17 908 211 904 198
Other 5-10 563 254 619 236
-
$37,388 $ 8,350 $37,431 $7,438
-
-
Three Months Ended
March 31,
2009 2008
-
Specialty Products $ 8,794 $ 8,450
Food, Pharma & Nutrition 8,304 9,289
Animal Nutrition & Health 35,888 39,122
-
Total $ 52,986 $ 56,861
-
Read the The complete Report
